Review





Similar Products

mouse antihuman ige antibody  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology mouse antihuman ige antibody
Mouse Antihuman Ige Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse antihuman ige antibody/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mouse antihuman ige antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
antihuman ige antibody  (SouthernBiotech)
93
SouthernBiotech antihuman ige antibody
Antihuman Ige Antibody, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antihuman ige antibody/product/SouthernBiotech
Average 93 stars, based on 1 article reviews
antihuman ige antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
antihuman ige monoclonal antibody  (SouthernBiotech)
93
SouthernBiotech antihuman ige monoclonal antibody
Antihuman Ige Monoclonal Antibody, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antihuman ige monoclonal antibody/product/SouthernBiotech
Average 93 stars, based on 1 article reviews
antihuman ige monoclonal antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
mouse antihuman bcl 2 antibody  (Proteintech)
96
Proteintech mouse antihuman bcl 2 antibody
Mouse Antihuman Bcl 2 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse antihuman bcl 2 antibody/product/Proteintech
Average 96 stars, based on 1 article reviews
mouse antihuman bcl 2 antibody - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
mouse antihuman kappa light chain igg  (R&D Systems)
93
R&D Systems mouse antihuman kappa light chain igg
Mouse Antihuman Kappa Light Chain Igg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse antihuman kappa light chain igg/product/R&D Systems
Average 93 stars, based on 1 article reviews
mouse antihuman kappa light chain igg - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
antihuman mouse angptl4  (Proteintech)
95
Proteintech antihuman mouse angptl4
Antihuman Mouse Angptl4, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antihuman mouse angptl4/product/Proteintech
Average 95 stars, based on 1 article reviews
antihuman mouse angptl4 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
hrp goat antihuman ige antibody  (SouthernBiotech)
93
SouthernBiotech hrp goat antihuman ige antibody
Hrp Goat Antihuman Ige Antibody, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hrp goat antihuman ige antibody/product/SouthernBiotech
Average 93 stars, based on 1 article reviews
hrp goat antihuman ige antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
mouse antihuman elf1 polyclonal antibody  (Proteintech)
93
Proteintech mouse antihuman elf1 polyclonal antibody
<t>ELF1</t> mRNA expression and diagnostic value in GC tissues. (A) ELF1 mRNA expression levels in cancerous tissues (red) and adjacent normal tissues (black) obtained from the GEPIA database. (B) Boxplot of ELF1 mRNA expression in 375 GC tissues and 32 GC adjacent tissue samples in the TCGA database as investigated using the R software. (C) ELF1 mRNA expression in 375 GC tissues and 32 GC adjacent tissue samples in the TCGA database as investigated using the R software (linear diagram). (D) ELF1 expression in tissue from the 40 patients with GC was measured using reverse transcription-quantitative PCR. (E) Receiver operating characteristic curve. STAD, stomach adenocarcinoma; GC, gastric cancer; AUC, area under the curve; ELF1, E74-like Factor 1.
Mouse Antihuman Elf1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse antihuman elf1 polyclonal antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
mouse antihuman elf1 polyclonal antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
mouse antihuman ceruloplasmin cp polyclonal antibody  (Proteintech)
93
Proteintech mouse antihuman ceruloplasmin cp polyclonal antibody
<t>ELF1</t> mRNA expression and diagnostic value in GC tissues. (A) ELF1 mRNA expression levels in cancerous tissues (red) and adjacent normal tissues (black) obtained from the GEPIA database. (B) Boxplot of ELF1 mRNA expression in 375 GC tissues and 32 GC adjacent tissue samples in the TCGA database as investigated using the R software. (C) ELF1 mRNA expression in 375 GC tissues and 32 GC adjacent tissue samples in the TCGA database as investigated using the R software (linear diagram). (D) ELF1 expression in tissue from the 40 patients with GC was measured using reverse transcription-quantitative PCR. (E) Receiver operating characteristic curve. STAD, stomach adenocarcinoma; GC, gastric cancer; AUC, area under the curve; ELF1, E74-like Factor 1.
Mouse Antihuman Ceruloplasmin Cp Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse antihuman ceruloplasmin cp polyclonal antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
mouse antihuman ceruloplasmin cp polyclonal antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

Image Search Results


ELF1 mRNA expression and diagnostic value in GC tissues. (A) ELF1 mRNA expression levels in cancerous tissues (red) and adjacent normal tissues (black) obtained from the GEPIA database. (B) Boxplot of ELF1 mRNA expression in 375 GC tissues and 32 GC adjacent tissue samples in the TCGA database as investigated using the R software. (C) ELF1 mRNA expression in 375 GC tissues and 32 GC adjacent tissue samples in the TCGA database as investigated using the R software (linear diagram). (D) ELF1 expression in tissue from the 40 patients with GC was measured using reverse transcription-quantitative PCR. (E) Receiver operating characteristic curve. STAD, stomach adenocarcinoma; GC, gastric cancer; AUC, area under the curve; ELF1, E74-like Factor 1.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: ELF1 mRNA expression and diagnostic value in GC tissues. (A) ELF1 mRNA expression levels in cancerous tissues (red) and adjacent normal tissues (black) obtained from the GEPIA database. (B) Boxplot of ELF1 mRNA expression in 375 GC tissues and 32 GC adjacent tissue samples in the TCGA database as investigated using the R software. (C) ELF1 mRNA expression in 375 GC tissues and 32 GC adjacent tissue samples in the TCGA database as investigated using the R software (linear diagram). (D) ELF1 expression in tissue from the 40 patients with GC was measured using reverse transcription-quantitative PCR. (E) Receiver operating characteristic curve. STAD, stomach adenocarcinoma; GC, gastric cancer; AUC, area under the curve; ELF1, E74-like Factor 1.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing, Diagnostic Assay, Software, Reverse Transcription, Real-time Polymerase Chain Reaction

ELF1 and MMP9 protein expression levels in GC and adjacent normal tissues as detected by immunohistochemistry. (A) Left, positive ELF1 expression in GC tumor cells (red arrow); right, ELF1 expression in lymphocytes in the GC mesenchyme. (B) Positive MMP9 expression in GC tissues (red arrow). (C) Left, weakly positive ELF1 expression in adjacent normal epithelial cells (green arrow); right, ELF1 expression in lymphocytes in normal mesenchyme. (D) Weakly positive MMP9 expression in adjacent normal tissues (green arrow). Original magnification x400 (scale bars, 50 µm); Smaller figures, original magnification x40 (scale bars, 500 µm). ELF1, E74-like Factor 1; GC, gastric cancer.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: ELF1 and MMP9 protein expression levels in GC and adjacent normal tissues as detected by immunohistochemistry. (A) Left, positive ELF1 expression in GC tumor cells (red arrow); right, ELF1 expression in lymphocytes in the GC mesenchyme. (B) Positive MMP9 expression in GC tissues (red arrow). (C) Left, weakly positive ELF1 expression in adjacent normal epithelial cells (green arrow); right, ELF1 expression in lymphocytes in normal mesenchyme. (D) Weakly positive MMP9 expression in adjacent normal tissues (green arrow). Original magnification x400 (scale bars, 50 µm); Smaller figures, original magnification x40 (scale bars, 500 µm). ELF1, E74-like Factor 1; GC, gastric cancer.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing, Immunohistochemistry

Expression of ELF1 and MMP9 by immunohistochemistry in GC and adjacent normal tissues (N=355).

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: Expression of ELF1 and MMP9 by immunohistochemistry in GC and adjacent normal tissues (N=355).

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing, Immunohistochemistry

Association between ELF1 and MMP9 protein expression positivity in tissue microarray according to immunohistochemistry in patients with gastric cancer.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: Association between ELF1 and MMP9 protein expression positivity in tissue microarray according to immunohistochemistry in patients with gastric cancer.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing, Microarray, Immunohistochemistry

Association of ELF1 and MMP9 expression by tissue microarray-immunohistochemistry with clinical characteristics in patients with GC.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: Association of ELF1 and MMP9 expression by tissue microarray-immunohistochemistry with clinical characteristics in patients with GC.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing, Microarray, Cell Differentiation

Kaplan-Meier survival analyses of patients with GC. (A) ELF1-high patients with GC (green line) exhibited inferior OS compared with those with ELF1-low expression (blue line). (B) MMP9-high patients with GC (green line) had inferior OS compared with that in MMP9-low patients (blue line). (C) Patients with GC and ELF1- and MMP9-high co-expression (purple line) had the worst OS among all groups compared. (D) Patients with the most advanced TNM stage had the shortest survival times. Censored data points indicate patients who were still alive until the end of follow-up. GC, gastric cancer; ELF1, E74-like Factor 1; Cum, cumulative; OS, overall survival.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: Kaplan-Meier survival analyses of patients with GC. (A) ELF1-high patients with GC (green line) exhibited inferior OS compared with those with ELF1-low expression (blue line). (B) MMP9-high patients with GC (green line) had inferior OS compared with that in MMP9-low patients (blue line). (C) Patients with GC and ELF1- and MMP9-high co-expression (purple line) had the worst OS among all groups compared. (D) Patients with the most advanced TNM stage had the shortest survival times. Censored data points indicate patients who were still alive until the end of follow-up. GC, gastric cancer; ELF1, E74-like Factor 1; Cum, cumulative; OS, overall survival.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing

Cox regression analysis of prognostic factors for 5-year survival from gastric cancer.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: Cox regression analysis of prognostic factors for 5-year survival from gastric cancer.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing

Correlation between ELF1 expression and that of MLH1, ERBB2, PIK3CA, TP53, MMP9, CDH1, TIMP1, VEGFA and KDR in GC tissues according to the GEPIA database. Correlation between ELF1 and (A) MLH1, (B) PIK3CA, (C) CDH1, (D) ERBB2, (E) TP53, (F) MMP9, (G) TIMP1, (H) VEGFA and (I) KDR. TPM, transcripts per kilobase of exon model per million mapped reads; ELF1, E74-like Factor 1; MLH1, MutL homolog 1; ERBB2, erythroblastic leukemia viral oncogene homolog 2; PIK3CA, PI3K subunit α; CDH1, cadherin 1; TIMP1, tissue inhibitors of metalloproteinases; KDR, kinase insert domain receptor.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: Correlation between ELF1 expression and that of MLH1, ERBB2, PIK3CA, TP53, MMP9, CDH1, TIMP1, VEGFA and KDR in GC tissues according to the GEPIA database. Correlation between ELF1 and (A) MLH1, (B) PIK3CA, (C) CDH1, (D) ERBB2, (E) TP53, (F) MMP9, (G) TIMP1, (H) VEGFA and (I) KDR. TPM, transcripts per kilobase of exon model per million mapped reads; ELF1, E74-like Factor 1; MLH1, MutL homolog 1; ERBB2, erythroblastic leukemia viral oncogene homolog 2; PIK3CA, PI3K subunit α; CDH1, cadherin 1; TIMP1, tissue inhibitors of metalloproteinases; KDR, kinase insert domain receptor.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing

Connection between ELF1 expression and immune cell infiltration in GC. (A) Correlation analysis of ELF1 expression and the degree of infiltration by the various immune cell types according to TIMER. (B) Infiltration results between high and low expression groups of ELF1. ELF1, E74-like Factor 1; TPM, transcripts per kilobase of exon model per million mapped reads; NK, natural killer.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: Connection between ELF1 expression and immune cell infiltration in GC. (A) Correlation analysis of ELF1 expression and the degree of infiltration by the various immune cell types according to TIMER. (B) Infiltration results between high and low expression groups of ELF1. ELF1, E74-like Factor 1; TPM, transcripts per kilobase of exon model per million mapped reads; NK, natural killer.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing

Association between ELF1 expression by tissue microarray-immunohistochemistry and that of different immune cell markers in GC.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: Association between ELF1 expression by tissue microarray-immunohistochemistry and that of different immune cell markers in GC.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Expressing, Microarray, Significance Assay

Association of ELF1 with CD19, CD3, CD4, CD8 and CD56 detected through immunohistochemical analysis. Magnification, x100; Scale bars, 250 µm). The red arrow indicates area of high protein expression, whilst the green arrow indicates areas of low protein expression. Upper, GC with ELF1 (+); lower, GC with ELF1 (-). ELF1, E74-like Factor 1.

Journal: Experimental and Therapeutic Medicine

Article Title: Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer

doi: 10.3892/etm.2024.12730

Figure Lengend Snippet: Association of ELF1 with CD19, CD3, CD4, CD8 and CD56 detected through immunohistochemical analysis. Magnification, x100; Scale bars, 250 µm). The red arrow indicates area of high protein expression, whilst the green arrow indicates areas of low protein expression. Upper, GC with ELF1 (+); lower, GC with ELF1 (-). ELF1, E74-like Factor 1.

Article Snippet: Subsequently, mouse antihuman ELF1 polyclonal antibody (dilution 1:400; cat. no. 22565-1-AP; ProteinTech Group, Inc.), MMP9 polyclonal antibody (dilution 1:300; cat. no. 10375-2-AP; ProteinTech Group, Inc.), mouse anti-human CD19 monoclonal (ready to use; cat. no. ZM-0038; ZSGB-BIO; OriGene Technologies, Inc.), mouse anti-human CD3 monoclonal (ready to use; cat. no. ZM-0417; ZSGB-BIO; OriGene Technologies, Inc.), mouse antihuman CD4 monoclonal (ready to use; cat. no. ZM-0418; ZSGB-BIO; OriGene Technologies, Inc.), rabbit anti-human CD8 monoclonal (ready to use; cat. no. ZM-0508 ZSGB-BIO; OriGene Technologies, Inc.) and mouse anti-human CD56 monoclonal (ready to use; cat. no. ZM-0057; ZSGB-BIO; OriGene Technologies, Inc.) were used for staining overnight at 4 ̊C.

Techniques: Immunohistochemical staining, Expressing